Clinical Trials Logo

Microsatellite Instability clinical trials

View clinical trials related to Microsatellite Instability.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04001101 Withdrawn - Colorectal Cancer Clinical Trials

Anti-PD-1 +/- RT for MSI-H Solid Tumors

Start date: October 10, 2019
Phase: Phase 2
Study type: Interventional

To determine if the out-of-field ORR is improved with the addition of radiation therapy to anti-PD-1 for patients with MSI-H/dMMR metastatic solid tumors. Determine the rates of in-field tumor control, disease control (stable disease, partial response, complete response), durability of disease response, progression-free survival, overall survival, and to assess quality of life and toxicity. Determine the chronology and profile of the radiation-associated immune response.

NCT ID: NCT02966587 Withdrawn - Clinical trials for Hormone-Resistant Prostate Cancer

Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Start date: May 15, 2018
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well durvalumab works in treating patients with prostate cancer that is resistant to hormones and has spread to other places in the body. Monoclonal antibodies, such as durvalumab, may interfere with the ability of tumor cells to grow and spread.